Literature DB >> 7969326

Brief report: variability of thrombosis among homozygous siblings with resistance to activated protein C due to an Arg-->Gln mutation in the gene for factor V.

J S Greengard1, S Eichinger, J H Griffin, K A Bauer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7969326     DOI： 10.1056/NEJM199412083312305

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  9 in total

Review 1.  Diagnosis and management of inherited and acquired thrombophilias.

Authors:  F A Spencer; R C Becker
Journal:  J Thromb Thrombolysis       Date:  1999-04       Impact factor: 2.300

2.  Prevalence of factor V leiden, MTHFR C677T and MTHFR A1298C polymorphisms in patients with deep vein thrombosis in Central Iran.

Authors:  Majid Ehsani; Aida Imani; Alireza Moravveji
Journal:  Mol Biol Rep       Date:  2018-05-31       Impact factor: 2.316

3.  Plasma resistance to activated protein C regulates the activation of coagulation induced by thrombolysis in patients with ischaemic heart disease.

Authors:  O D Pedersen; J Gram; J Jespersen
Journal:  Heart       Date:  1997-02       Impact factor: 5.994

4.  Celiac artery embolism due to thrombophilia - a case report.

Authors:  George Trellopoulos; Maria I Pikilidou; Evaggelia Tsiga
Journal:  Int J Angiol       Date:  2009

5.  Guidelines for the management of thrombophilia. Department of Haematology, The Royal London Hospital, Whitechapel, London, UK.

Authors:  J D Cavenagh; B T Colvin
Journal:  Postgrad Med J       Date:  1996-02       Impact factor: 2.401

6.  Symptomatic combined homozygous factor XII deficiency and heterozygous factor V Leiden. luscaber@tin.it.

Authors:  A Girolami; P Simioni; L Scarano; B Girolami; P Zerbinati
Journal:  J Thromb Thrombolysis       Date:  2000-04       Impact factor: 2.300

7.  Factor V Leiden: who should be tested?

Authors:  S Solymoss
Journal:  CMAJ       Date:  1996-08-01       Impact factor: 8.262

8.  No Prognostic Importance of Resistance to Activated Protein C in Unstable Coronary Artery Disease Despite Signs of Thrombin Activation.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1998       Impact factor: 2.300

9.  Factor V Leiden and Prothrombin 20210A Mutations among Turkish Pediatric Leukemia Patients.

Authors:  Dilara Fatma Akın; Kadir Sipahi; Tuğba Kayaalp; Yonca Eğin; Serpil Taşdelen; Emin Kürekçi; Ustün Ezer; Nejat Akar
Journal:  Leuk Res Treatment       Date:  2012-02-16
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.